Evidence map›Paper›PMID 34518525›Full record

ArticleNature communications2021

Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence.

Emma L Davis, Tim C D Lucas, Anna Borlase, Timothy M Pollington, Sam Abbott, Diepreye Ayabina, Thomas Crellen, Joel Hellewell, Li Pi, CMMID COVID-19 Working Group and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Time trends and modifiable factors of COVID-19 contact tracing coverage, Geneva, Switzerland, June 2020 to February 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  18. Article
  19. Effectiveness of SARS-CoV-2 testing strategies: A scoping review.Cochrane evidence synthesis and methods · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emma L Davis *Big Data Institute, University of Oxford, Oxford, UK. emma.davis@bdi.ox.ac.uk.ORCID 0000-0001-6261-775X
Tim C D Lucas *Big Data Institute, University of Oxford, Oxford, UK.ORCID 0000-0003-4694-8107
Anna BorlaseBig Data Institute, University of Oxford, Oxford, UK.ORCID 0000-0002-3189-7047
Timothy M PollingtonBig Data Institute, University of Oxford, Oxford, UK.ORCID 0000-0002-9688-5960
Sam AbbottDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Diepreye AyabinaBig Data Institute, University of Oxford, Oxford, UK.
Thomas CrellenBig Data Institute, University of Oxford, Oxford, UK.ORCID 0000-0003-2934-1063
Joel HellewellDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Li PiBig Data Institute, University of Oxford, Oxford, UK.
CMMID COVID-19 Working Group
Graham F MedleyCentre for Mathematical Modelling of Infectious Disease & Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-0030-7278
T Déirdre HollingsworthBig Data Institute, University of Oxford, Oxford, UK.ORCID 0000-0001-5962-4238
Petra KlepacDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-4132-3933

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) OPP1184344Medical Research Council MC_PC_19012Medical Research Council MR/R015600/1RCUK | Medical Research Council (MRC) MR/V028618/1RCUK | Medical Research Council (MRC) MR/V038613/1Wellcome Trust 208812/Z/17/Z
6 · The paper itself

Abstract

Emerging evidence suggests that contact tracing has had limited success in the UK in reducing the R number across the COVID-19 pandemic. We investigate potential pitfalls and areas for improvement by extending an existing branching process contact tracing model, adding diagnostic testing and refining parameter estimates. Our results demonstrate that reporting and adherence are the most important predictors of programme impact but tracing coverage and speed plus diagnostic sensitivity also play an important role. We conclude that well-implemented contact tracing could bring small but potentially important benefits to controlling and preventing outbreaks, providing up to a 15% reduction in R. We reaffirm that contact tracing is not currently appropriate as the sole control measure.

Indexed as

PandemicsContact TracingCOVID-19COVID-19 TestingDisease OutbreaksHumansQuarantineSARS-CoV-2Sensitivity and SpecificityUnited Kingdom

Identifiers

PMID34518525
PMCPMC8438018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.